2C-CP
Chemical compound
From Wikipedia, the free encyclopedia
2C-CP, or 2C-cP, also known as 4-cyclopropyl-2,5-dimethoxyphenethylamine, is a psychedelic and designer drug of the phenethylamine and 2C families.[1] It was first synthesized by Daniel Trachsel and colleagues in 2006 and was subsequently described by them in the literature in 2013.[1] The drug has an affinity (Ki) of 95 nM at the serotonin 5-HT2A receptor and of 41 nM at the 5-HT2C receptor.[1] 2C-CP is active at a dose of between 15 and 35 mg orally with a duration of 3 to 6 hours.[1] Its effects were described as rather diffuse and undefinable, with its full effects having not yet been explored.[1] Analogues of 2C-CP include 2C-CPE, 2C-IP, 2C-P, 2C-T-15, 2C-V, and 2C-YN, among others.[1][2] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[3] It is not an explicitly controlled substance in the United States,[4] but it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
| |
| Clinical data | |
|---|---|
| Other names | 2C-cP; 4-Cyclopropyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-cyclopropylphenethylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO2 |
| Molar mass | 221.300 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
